Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Consolidated Appropriations Act, 2019
Client: ARE YOU DENSE ADVOCACY, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Breast Density and Mammography Reporting Act; H.J. Res. 31 The Consolidated Appropriations Act of 2019.
Cancer Drug Parity Act of 2019
Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1730/ S. 741 The Cancer Drug Parity Act.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
INTERNATIONAL MYELOMA FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2019 · third_quarter · 3T
H.R. 1730 The Cancer Drug Parity Act.
Filing targets: HOUSE OF REPRESENTATIVES
IFB SOLUTIONS via FAEGRE DRINKER BIDDLE & REATH LLP
2019 · second_quarter · Q2
Source: Senate LDA
| INTERNATIONAL MYELOMA FOUNDATION |
| 21 |
| 2015–2019 |
| INTERNATIONAL PHARMACEUTICAL AEROSOL CONSORTIUM | 11 | 2008–2012 |
| OVARIAN CANCER RESEARCH FUND ALLIANCE | 11 | 2016–2018 |
| ARE YOU DENSE ADVOCACY, INC. | 10 | 2016–2019 |
| COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS | 10 | 2017–2019 |
| OVARIAN CANCER NATIONAL ALLIANCE | 10 | 2013–2015 |
| ADVANCED INITIATIVES IN MEDICAL SIMULATION | 9 | 2007–2010 |
| AMERICAN NEPHROLOGY NURSES ASSOCIATION | 6 | 2007–2008 |
| LUPUS FOUNDATION OF AMERICA | 6 | 2007–2009 |
| NATIONAL ATHLETIC TRAINERS' ASSOCIATION | 5 | 2008–2009 |
| NATIONAL PSORIASIS FOUNDATION | 5 | 2007–2013 |
| PATIENT ACCESS NETWORK FOUNDATION | 5 | 2017–2019 |
| CALM/CHATT COALITION (NAME CHANGE: FORMERLY CHATT COALITION) | 4 | 2007–2008 |
| CHILDREN'S CARDIOMYOPATHY FOUNDATION, INC. | 4 | 2014–2015 |
| HELENA AGRI-ENTERPRISES LLC | 4 | 2016–2019 |
| NATIONAL ASSOCIATION FOR HOME CARE & HOSPICE | 4 | 2007–2008 |
| AMERICAN ASSOCIATION OF OCCUPATIONAL HEALTH NURSES | 3 | 2007–2008 |
| BOSMA ENTERPRISES | 3 | 2019 |
| IFB SOLUTIONS | 3 | 2019 |
| J.B. HUNT TRANSPORT, INC. | 3 | 2015 |
| MARCH OF DIMES FOUNDATION | 3 | 2012 |
| ADVOCATE AURORA HEALTH INC | 2 | 2007 |
| AMERICAN COLLEGE OF NURSE PRACTITIONERS | 2 | 2007 |
| AMERICAN FOUNDATION FOR THE BLIND | 2 | 2013 |
| AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE | 2 | 2007 |
| CURE SMA | 2 | 2016 |
| SOCIETY OF NUCLEAR MEDICINE | 2 | 2007 |
| STRYKER CORPORATION | 2 | 2008 |
| CONVATEC | 1 | 2009 |
| HARM REDUCTION COALITION | 1 | 2013 |
| INTERNATIONAL UNDERWRITING ASSOCIATION OF LONDON | 1 | 2013 |
| SMITH & NEPHEW INC | 1 | 2013 |
| THE REHABILITATION INNOVATION CENTERS COALITION | 1 | 2018 |
| TT CLUB MUTUAL INSURANCE COMPANY LIMITED | 1 | 2013 |
Cancer Drug Parity Act of 2019
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Drug price monitoring; H.R. 1730, S. 741 The Cancer Drug Parity Act.
Cancer Drug Parity Act of 2019
Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1730/ S. 741 The Cancer Drug Parity Act.
Cancer Drug Parity Act of 2019
Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1730 The Cancer Drug Parity Act.
Patient-Centered Outcomes Research Extension Act of 2019
Client: ASSOCIATION OF REHABILITATION NURSES · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 1399, H.R. 728 Title VIII Nursing Workforce Reauthorization Act of 2019; H.R. 3030 Patient-Centered Outcomes Research Extension Act of 2019.
Title VIII Nursing Workforce Reauthorization Act of 2019
Client: ASSOCIATION OF REHABILITATION NURSES · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 1399, H.R. 728 Title VIII Nursing Workforce Reauthorization Act of 2019; H.R. 3030 Patient-Centered Outcomes Research Extension Act of 2019.
Threat Assessment, Prevention, and Safety Act of 2019
Client: COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Provider status for pharmacists; drug pricing; H.R. The Medicaid Reentry Act; H.R. 838/ S. 265 The Treatment Assesment, Prevention, and Safety Act.
CLINICAL TREATMENT Act
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Drug price monitoring; H.R. 913 The Ckubucak Treatment Act; S. 741 The Cancer Drug Parity Act.
Title VIII Nursing Workforce Reauthorization Act of 2019
Client: ASSOCIATION OF REHABILITATION NURSES · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 1399, H.R. 728 Title VIII Nursing Workforce Reauthorization Act of 2019; H.R. 3030 Patient-Centered Outcomes Research Extension Act of 2019.
Threat Assessment, Prevention, and Safety Act of 2019
Client: COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Provider status for pharmacists; drug pricing; H.R. The Medicaid Reentry Act; H.R. 838/ S. 265 The Treatment Assesment, Prevention, and Safety Act.
REFUND Act of 2019
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 551 The REFUND Act; Provider status for pharmacists.
REFUND Act of 2019
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 551 The REFUND Act; Provider status for pharmacists.
Cancer Drug Parity Act of 2019
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Drug price monitoring; H.R. 913 The Ckubucak Treatment Act; S. 741 The Cancer Drug Parity Act.
Cancer Drug Parity Act of 2019
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Drug price monitoring; H.R. 1730, S. 741 The Cancer Drug Parity Act.
Cancer Drug Parity Act of 2019
Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1730/ S. 741 The Cancer Drug Parity Act.
Cancer Drug Parity Act of 2019
Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1730/ S. 741 The Cancer Drug Parity Act.
Pesticide Registration Improvement Extension Act of 2018
Client: HELENA AGRI-ENTERPRISES LLC · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Agriculture and farm bill issues; HR 1029, Pesticide Registration Improvement Extension Act; S. 3032 Strengthening the Tenth Amendment Through Entrusting States Act; HR. 4881 Precision Agriculture Connectivity Act of 2018.
Cancer Drug Parity Act of 2017
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1409 Cancer Drug Parity Act; H.R. 5247, Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018; letter to Finance Committee on opioid crisis; Letter to Ways & Means Committee on opioid crisis.
Cancer Drug Parity Act of 2017
Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1409 The Cancer Drug Parity Act
Cancer Drug Parity Act of 2017
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1409 Cancer Drug Parity Act; S. 2554/HR. 6143 Patient Right to Know Drug Prices Act; Opioid Monitoring; Drug pricing Monitoring; S. 2680 Opioid Crisis Response Act; H.R.6 Support for Patients and Communities Act.
Cancer Drug Parity Act of 2017
Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1409 The Cancer Drug Parity Act
Cancer Drug Parity Act of 2017
Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1409 The Cancer Drug Parity Act
Cancer Drug Parity Act of 2017
Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1409 The Cancer Drug Parity Act
Cancer Drug Parity Act of 2017
Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1409 The Cancer Drug Parity Act
Cancer Drug Parity Act of 2017
Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1409 The Cancer Drug Parity Act
Cancer Drug Parity Act of 2017
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1409 Cancer Drug Parity Act; H.R. 5247, Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018; S. 2554/HR. 6143 Patient Right to Know Drug Prices Act; Opioid Monitoring; Drug pricing Monitoring, HR. 592/ S. 109 Pharmacy and Medically Underserved Areas Enhancement Act.
Consolidated Appropriations Act, 2018
Client: SPINA BIFIDA ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
FY 2018 Health and Human Services (HHS) appropriations supporting the National Spina Bifida Program at the Centers for Disease Control (CDC); H.R. 1625, the Consolidated Appropriations Act, FY 2019 Health and Human Services (HHS) appropriations supporting the NSBP at the CDC.
Consolidated Appropriations Act, 2018
Client: PREVENT BLINDNESS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
FY 2018 HHS appropriations related to vision health/ HR 1625 the Consolidated Appropriations Act; FY 2019 Labor Health and Human Services and Education (HHS) appropriations related to vision; eye health
Consolidated Appropriations Act, 2018
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
FY 2018 Omnibus Appropriations Bill (HR 1625, the Consolidated Appropriations Act); FY 2019 Labor, Health & Human Services and Education (HHS) appropriations related to ovarian cancer programs.
National Suicide Hotline Improvement Act of 2018
Client: COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Mental health issues; Opioid Issues; House Ways and Means Committee letter on opioid crisis; finance committee letter on opioid crisis; HR 4778/ S. 2301, the Behavior Health Coverage Transparency Act; HR 3991, The Expanded Access to Opioid Abuse Treatment Act; HR 2345, the National Suicide Hotline Improvement Act; HR 5311/ S. 2456, the CARA 2.0 Act; HR 3692/ S 2317 Addiction Treatment Access Improvement Act.
Addiction Treatment Access Improvement Act of 2017
Client: COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Mental health issues; Opioid Issues; House Ways and Means Committee letter on opioid crisis; finance committee letter on opioid crisis; HR 4778/ S. 2301, the Behavior Health Coverage Transparency Act; HR 3991, The Expanded Access to Opioid Abuse Treatment Act; HR 2345, the National Suicide Hotline Improvement Act; HR 5311/ S. 2456, the CARA 2.0 Act; HR 3692/ S 2317 Addiction Treatment Access Improvement Act.
Expanded Access to Opioid Abuse Treatment Act of 2017
Client: COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Mental health issues; Opioid Issues; House Ways and Means Committee letter on opioid crisis; finance committee letter on opioid crisis; HR 4778/ S. 2301, the Behavior Health Coverage Transparency Act; HR 3991, The Expanded Access to Opioid Abuse Treatment Act; HR 2345, the National Suicide Hotline Improvement Act; HR 5311/ S. 2456, the CARA 2.0 Act; HR 3692/ S 2317 Addiction Treatment Access Improvement Act.
Breast Density and Mammography Reporting Act of 2017
Client: ARE YOU DENSE ADVOCACY, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 2006/ H.R. 4122, The Breast Density and Mammography Reporting Act.
Breast Density and Mammography Reporting Act of 2017
Client: ARE YOU DENSE ADVOCACY, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 2006/ H.R. 4122, The Breast Density and Mammography Reporting Act.
Preserving Rehabilitation Innovation Centers Act of 2017
Client: THE REHABILITATION INNOVATION CENTERS COALITION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Impatient Rehabilitation Issues; HR 4582/ S 2204 Preserving Rehabilitation Innovation Centers Act.
Behavioral Health Coverage Transparency Act of 2018
Client: COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Mental health issues; Opioid Issues; House Ways and Means Committee letter on opioid crisis; finance committee letter on opioid crisis; HR 4778/ S. 2301, the Behavior Health Coverage Transparency Act; HR 3991, The Expanded Access to Opioid Abuse Treatment Act; HR 2345, the National Suicide Hotline Improvement Act; HR 5311/ S. 2456, the CARA 2.0 Act; HR 3692/ S 2317 Addiction Treatment Access Improvement Act.
Precision Agriculture Connectivity Act of 2018
Client: HELENA AGRI-ENTERPRISES LLC · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Agriculture and farm bill issues; HR 1029, Pesticide Registration Improvement Extension Act; S. 3032 Strengthening the Tenth Amendment Through Entrusting States Act; HR. 4881 Precision Agriculture Connectivity Act of 2018.
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1409 Cancer Drug Parity Act; H.R. 5247, Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018; S. 2554/HR. 6143 Patient Right to Know Drug Prices Act; Opioid Monitoring; Drug pricing Monitoring, HR. 592/ S. 109 Pharmacy and Medically Underserved Areas Enhancement Act.
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1409 Cancer Drug Parity Act; H.R. 5247, Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018; letter to Finance Committee on opioid crisis; Letter to Ways & Means Committee on opioid crisis.
CARA 2.0 Act of 2018
Client: COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Mental health issues; Opioid Issues; House Ways and Means Committee letter on opioid crisis; finance committee letter on opioid crisis; HR 4778/ S. 2301, the Behavior Health Coverage Transparency Act; HR 3991, The Expanded Access to Opioid Abuse Treatment Act; HR 2345, the National Suicide Hotline Improvement Act; HR 5311/ S. 2456, the CARA 2.0 Act; HR 3692/ S 2317 Addiction Treatment Access Improvement Act.
Pharmacy and Medically Underserved Areas Enhancement Act
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1409 Cancer Drug Parity Act; H.R. 5247, Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018; S. 2554/HR. 6143 Patient Right to Know Drug Prices Act; Opioid Monitoring; Drug pricing Monitoring, HR. 592/ S. 109 Pharmacy and Medically Underserved Areas Enhancement Act.
Pharmacy and Medically Underserved Areas Enhancement Act
Client: COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
HR 592/ S. 109, Pharmacy and Medically Underserved Areas Enhancement Act.
Pharmacy and Medically Underserved Areas Enhancement Act
Client: COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 109/H.R. 592 The Pharmacy and Medically Underserved Areas Enhancement Act.
SUPPORT for Patients and Communities Act
Client: COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Mental health issues; Opioid Issues; Draft opioid legislation; Including Families in Mental Health Recovery Act; S. 2524 Substance Use Disorder Workforce Loan Repayment Act of 2018; S. 2680 Opioid Crisis Response Act; HR. 6 Support for Patients and Communities Act.
SUPPORT for Patients and Communities Act
Client: COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Mental health issues; Opioid Issues; Draft opioid legislation; S. 2680 Opioid Crisis Response Act; HR. 6 Support for Patients and Communities Act; H.R.6597 Mental Health Professionals Workforce Shortage Loan Repayment Act.
SUPPORT for Patients and Communities Act
Client: ASSOCIATION OF REHABILITATION NURSES · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 6 Support for Patients and Communities Act; S. 2680 Opioid Crisis Response Act
SUPPORT for Patients and Communities Act
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1409 Cancer Drug Parity Act; S. 2554/HR. 6143 Patient Right to Know Drug Prices Act; Opioid Monitoring; Drug pricing Monitoring; S. 2680 Opioid Crisis Response Act; H.R.6 Support for Patients and Communities Act.
Patient Right to Know Drug Prices Act
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1409 Cancer Drug Parity Act; S. 2554/HR. 6143 Patient Right to Know Drug Prices Act; Opioid Monitoring; Drug pricing Monitoring; S. 2680 Opioid Crisis Response Act; H.R.6 Support for Patients and Communities Act.
Patient Right to Know Drug Prices Act
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1409 Cancer Drug Parity Act; H.R. 5247, Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018; S. 2554/HR. 6143 Patient Right to Know Drug Prices Act; Opioid Monitoring; Drug pricing Monitoring, HR. 592/ S. 109 Pharmacy and Medically Underserved Areas Enhancement Act.
Mental Health Professionals Workforce Shortage Loan Repayment Act of 2018
Client: COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Mental health issues; Opioid Issues; Draft opioid legislation; S. 2680 Opioid Crisis Response Act; HR. 6 Support for Patients and Communities Act; H.R.6597 Mental Health Professionals Workforce Shortage Loan Repayment Act.
CLINICAL TREATMENT Act
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Drug pricing Monitoring; H.R. 6836 The Clinical Treatment Act.
Pharmacy and Medically Underserved Areas Enhancement Act
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1409 Cancer Drug Parity Act; H.R. 5247, Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018; S. 2554/HR. 6143 Patient Right to Know Drug Prices Act; Opioid Monitoring; Drug pricing Monitoring, HR. 592/ S. 109 Pharmacy and Medically Underserved Areas Enhancement Act.
Pharmacy and Medically Underserved Areas Enhancement Act
Client: COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 109/H.R. 592 The Pharmacy and Medically Underserved Areas Enhancement Act.
Pharmacy and Medically Underserved Areas Enhancement Act
Client: COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
HR 592/ S. 109, Pharmacy and Medically Underserved Areas Enhancement Act.
Breast Density and Mammography Reporting Act of 2017
Client: ARE YOU DENSE ADVOCACY, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 2006, The Breast Density and Mammography Reporting Act.
Breast Density and Mammography Reporting Act of 2017
Client: ARE YOU DENSE ADVOCACY, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 2006/ H.R. 4122, The Breast Density and Mammography Reporting Act.
Breast Density and Mammography Reporting Act of 2017
Client: ARE YOU DENSE ADVOCACY, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 2006/ H.R. 4122, The Breast Density and Mammography Reporting Act.
Preserving Rehabilitation Innovation Centers Act of 2017
Client: THE REHABILITATION INNOVATION CENTERS COALITION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Impatient Rehabilitation Issues; HR 4582/ S 2204 Preserving Rehabilitation Innovation Centers Act.
Behavioral Health Coverage Transparency Act of 2018
Client: COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Mental health issues; Opioid Issues; House Ways and Means Committee letter on opioid crisis; finance committee letter on opioid crisis; HR 4778/ S. 2301, the Behavior Health Coverage Transparency Act; HR 3991, The Expanded Access to Opioid Abuse Treatment Act; HR 2345, the National Suicide Hotline Improvement Act; HR 5311/ S. 2456, the CARA 2.0 Act; HR 3692/ S 2317 Addiction Treatment Access Improvement Act.
Addiction Treatment Access Improvement Act of 2018
Client: COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Mental health issues; Opioid Issues; House Ways and Means Committee letter on opioid crisis; finance committee letter on opioid crisis; HR 4778/ S. 2301, the Behavior Health Coverage Transparency Act; HR 3991, The Expanded Access to Opioid Abuse Treatment Act; HR 2345, the National Suicide Hotline Improvement Act; HR 5311/ S. 2456, the CARA 2.0 Act; HR 3692/ S 2317 Addiction Treatment Access Improvement Act.
CARA 2.0 Act of 2018
Client: COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Mental health issues; Opioid Issues; House Ways and Means Committee letter on opioid crisis; finance committee letter on opioid crisis; HR 4778/ S. 2301, the Behavior Health Coverage Transparency Act; HR 3991, The Expanded Access to Opioid Abuse Treatment Act; HR 2345, the National Suicide Hotline Improvement Act; HR 5311/ S. 2456, the CARA 2.0 Act; HR 3692/ S 2317 Addiction Treatment Access Improvement Act.
Substance Use Disorder Workforce Loan Repayment Act of 2018
Client: COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Mental health issues; Opioid Issues; Draft opioid legislation; Including Families in Mental Health Recovery Act; S. 2524 Substance Use Disorder Workforce Loan Repayment Act of 2018; S. 2680 Opioid Crisis Response Act; HR. 6 Support for Patients and Communities Act.
Patient Right to Know Drug Prices Act
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1409 Cancer Drug Parity Act; S. 2554/HR. 6143 Patient Right to Know Drug Prices Act; Opioid Monitoring; Drug pricing Monitoring; S. 2680 Opioid Crisis Response Act; H.R.6 Support for Patients and Communities Act.
Patient Right to Know Drug Prices Act
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1409 Cancer Drug Parity Act; H.R. 5247, Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018; S. 2554/HR. 6143 Patient Right to Know Drug Prices Act; Opioid Monitoring; Drug pricing Monitoring, HR. 592/ S. 109 Pharmacy and Medically Underserved Areas Enhancement Act.
Opioid Crisis Response Act of 2018
Client: ASSOCIATION OF REHABILITATION NURSES · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 6 Support for Patients and Communities Act; S. 2680 Opioid Crisis Response Act
Opioid Crisis Response Act of 2018
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1409 Cancer Drug Parity Act; S. 2554/HR. 6143 Patient Right to Know Drug Prices Act; Opioid Monitoring; Drug pricing Monitoring; S. 2680 Opioid Crisis Response Act; H.R.6 Support for Patients and Communities Act.
Opioid Crisis Response Act of 2018
Client: COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Mental health issues; Opioid Issues; Draft opioid legislation; S. 2680 Opioid Crisis Response Act; HR. 6 Support for Patients and Communities Act; H.R.6597 Mental Health Professionals Workforce Shortage Loan Repayment Act.
Opioid Crisis Response Act of 2018
Client: COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Mental health issues; Opioid Issues; Draft opioid legislation; Including Families in Mental Health Recovery Act; S. 2524 Substance Use Disorder Workforce Loan Repayment Act of 2018; S. 2680 Opioid Crisis Response Act; HR. 6 Support for Patients and Communities Act.
Agriculture and farm bill issues; HR 1029, Pesticide Registration Improvement Extension Act; S. 3032 Strengthening the Tenth Amendment Through Entrusting States Act; HR. 4881 Precision Agriculture Connectivity Act of 2018.
To amend title XVIII of the Social Security Act to allow physician assistants, nurse practitioners, and clinical nurse specialists to supervise cardiac, intensive cardiac, and pulmonary rehabilitation programs.
Client: ASSOCIATION OF REHABILITATION NURSES · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
HR 1155 Cardiac Rehabilitation; Promoting appropriate quality measures and outcomes across the post-acute continuum
Cancer Drug Parity Act of 2017
Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1409 The Cancer Drug Parity Act
Cancer Drug Parity Act of 2017
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
HR 1409 The Cancer Drug Parity Act.
Cancer Drug Parity Act of 2017
Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1409 The Cancer Drug Parity Act
Cancer Drug Parity Act of 2017
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1409 Cancer Drug Parity Act
Cancer Drug Parity Act of 2017
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1409 Cancer Drug Parity Act
Cancer Drug Parity Act of 2017
Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1409 The Cancer Drug Parity Act
Cancer Drug Parity Act of 2017
Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1409 The Cancer Drug Parity Act
Breast Density and Mammography Reporting Act of 2017
Client: ARE YOU DENSE ADVOCACY, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 2006/ H.R. 4122, The Breast Density and Mammography Reporting Act.
Pharmacy and Medically Underserved Areas Enhancement Act
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 109/ H.R. 592- The Pharmacy and Medically Undeserved Areas Enhancement Act.
Pharmacy and Medically Underserved Areas Enhancement Act
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 109/ H.R. 592- The Pharmacy and Medically Undeserved Areas Enhancement Act.
Pharmacy and Medically Underserved Areas Enhancement Act
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 109/ H.R. 592- The Pharmacy and Medically Undeserved Areas Enhancement Act.
Pharmacy and Medically Underserved Areas Enhancement Act
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 109/ H.R. 592- The Pharmacy and Medically Undeserved Areas Enhancement Act.
Pharmacy and Medically Underserved Areas Enhancement Act
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 109/ H.R. 592- The Pharmacy and Medically Undeserved Areas Enhancement Act.
Pharmacy and Medically Underserved Areas Enhancement Act
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 109/ H.R. 592- The Pharmacy and Medically Undeserved Areas Enhancement Act.
Pharmacy and Medically Underserved Areas Enhancement Act
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 109/ H.R. 592- The Pharmacy and Medically Undeserved Areas Enhancement Act.
Pharmacy and Medically Underserved Areas Enhancement Act
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 109/ H.R. 592- The Pharmacy and Medically Undeserved Areas Enhancement Act.
Breast Density and Mammography Reporting Act of 2017
Client: ARE YOU DENSE ADVOCACY, INC. · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 2006/ H.R. 4122, The Breast Density and Mammography Reporting Act.
Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017
Client: ASSOCIATION OF REHABILITATION NURSES · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 870 Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017; Chronic care return; Value based purchasing.
National Health Service Corps Improvement Act of 2015
Client: PREVENT BLINDNESS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
HR 1312/ S 898- the National Health Services Corps Improvement Act.
Enhancing the Stature and Visibility of Medical Rehabilitation Research at NIH Act
Client: ASSOCIATION OF REHABILITATION NURSES · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
HR 952 - Put a Registered Nurse in the Nursing Home Act; H.R. 4878- Better Care, Lower Cost Act; S. 800/ HR 1631 the Enhancing the Stature and Visibility of Medical and Rehabilitation Research at NIH Act.
Cancer Drug Coverage Parity Act of 2015
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
HR 2739/ S1566- the Cancer Drug Coverage Parity Act
Cancer Drug Coverage Parity Act of 2015
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 1566/HR 2739 - Cancer Drug Coverage Parity Act.
Cancer Drug Coverage Parity Act of 2015
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Report Language for Johanna's Law and the Ovarian Cancer Control Initiative at the CDC for Fiscal Year 2017 Appropriations; FY2017 funding for implementation of IOM report on ovarian cancer; Implementation of Johanna's Law/Inside Knowledge Campaign and Ovarian Campaign Control Program; HR 2739/S 2566, the Cancer Drug Coverage Parity Act
Cancer Drug Coverage Parity Act of 2015
Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 1566/HR 2739 - Cancer Drug Coverage Parity Act.
Cancer Drug Coverage Parity Act of 2015
Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 1566/HR 2739 - Cancer Drug Coverage Parity Act.
Cancer Drug Coverage Parity Act of 2015
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 1566/HR 2739 - Cancer Drug Coverage Parity Act; Cancer Moonshot Initiative.
Cancer Drug Coverage Parity Act of 2015
Client: OVARIAN CANCER RESEARCH FUND ALLIANCE · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Report Language for Johanna's Law and the Ovarian Cancer Control Initiative at the CDC for Fiscal Year 2017 Appropriations; FY2017 funding for implementation of IOM report on ovarian cancer; Implementation of Johanna's Law/Inside Knowledge Campaign and Ovarian Campaign Control Program; HR 2739/S 2566, the Cancer Drug Coverage Parity Act
Cancer Drug Coverage Parity Act of 2015
Client: HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 1566/HR 2739 - Cancer Drug Coverage Parity Act; 21st Century Cures Act.
Cancer Drug Coverage Parity Act of 2015
Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
S. 1566/HR 2739 - Cancer Drug Coverage Parity Act.
VA MilCon appropriations report language regarding disability programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOSMA ENTERPRISES via FAEGRE DRINKER BIDDLE & REATH LLP
2019 · second_quarter · Q2
VA MilCon appropriations report language regarding disability programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF REHABILITATION NURSES via FAEGRE DRINKER BIDDLE & REATH LLP
2019 · second_quarter · Q2
S. 1399, H.R. 728 Title VIII Nursing Workforce Reauthorization Act of 2019; H.R. 3030 Patient-Centered Outcomes Research Extension Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2019 · second_quarter · Q2
S. 551 The REFUND Act; Provider status for pharmacists.
Drug price monitoring; H.R. 1730, S. 741 The Cancer Drug Parity Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERNATIONAL MYELOMA FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2019 · second_quarter · Q2
H.R. 1730/ S. 741 The Cancer Drug Parity Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PATIENT ACCESS NETWORK FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2019 · second_quarter · Q2
Medicare Part D Out of Pocket Costs.
IFB SOLUTIONS via FAEGRE DRINKER BIDDLE & REATH LLP
2019 · first_quarter · Q1
VA-MilCon appropriations report language.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOSMA ENTERPRISES via FAEGRE DRINKER BIDDLE & REATH LLP
2019 · first_quarter · Q1
VA-MilCon appropriations report language.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IFB SOLUTIONS via FAEGRE DRINKER BIDDLE & REATH LLP
2019 · first_quarter · RR
VA-MilCon appropriations report language.
BOSMA ENTERPRISES via FAEGRE DRINKER BIDDLE & REATH LLP
2019 · first_quarter · RR
VA-MilCon appropriations report language.
HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2019 · first_quarter · Q1
FY 2020 Health and Human Services (HHS) appropriations supporting NIH and CDC funding.
Drug price monitoring; H.R. 913 The Ckubucak Treatment Act; S. 741 The Cancer Drug Parity Act.
S. 551 The REFUND Act; Provider status for pharmacists.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS via FAEGRE DRINKER BIDDLE & REATH LLP
2019 · first_quarter · Q1
Provider status for pharmacists; drug pricing; H.R. The Medicaid Reentry Act; H.R. 838/ S. 265 The Treatment Assesment, Prevention, and Safety Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARE YOU DENSE ADVOCACY, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2019 · first_quarter · Q1
Breast Density and Mammography Reporting Act; H.J. Res. 31 The Consolidated Appropriations Act of 2019.
Filing targets: SENATE
ASSOCIATION OF REHABILITATION NURSES via FAEGRE DRINKER BIDDLE & REATH LLP
2019 · first_quarter · Q1
FY 2020 Health and Human Services (HHS) Appropriations supporting HRSA Title VIII and CDC TBI funding.
SPINA BIFIDA ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2019 · first_quarter · Q1
FY 2020 Health and Human Services (HHS) appropriations supporting the National Spina Bifida Program at the CDC.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERNATIONAL MYELOMA FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2019 · first_quarter · Q1
H.R. 1730/ S. 741 The Cancer Drug Parity Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HELENA AGRI-ENTERPRISES LLC via FAEGRE DRINKER BIDDLE & REATH LLP
2019 · first_quarter · Q1
Agriculture farm bill issues; Trade issues pertaining to agriculture; pesticide labeling for hemp.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERNATIONAL MYELOMA FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · first_quarter · 1A
H.R. 1409 The Cancer Drug Parity Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · fourth_quarter · Q4
Drug pricing Monitoring; H.R. 6836 The Clinical Treatment Act.
INTERNATIONAL MYELOMA FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · fourth_quarter · Q4
H.R. 1409 The Cancer Drug Parity Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SPINA BIFIDA ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · fourth_quarter · Q4
FY 2019 Health and Human Services (HHS) appropriations supporting the NSBP at the CDC.
Filing targets: HOUSE OF REPRESENTATIVES
COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · fourth_quarter · Q4
S. 109/H.R. 592 The Pharmacy and Medically Underserved Areas Enhancement Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · third_quarter · Q3
FY 2019 Health and Human Services (HHS) Appropriations supporting HRSA Title VII workforce programs.
Mental health issues; Opioid Issues; Draft opioid legislation; S. 2680 Opioid Crisis Response Act; HR. 6 Support for Patients and Communities Act; H.R.6597 Mental Health Professionals Workforce Shortage Loan Repayment Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF REHABILITATION NURSES via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · third_quarter · Q3
H.R. 6 Support for Patients and Communities Act; S. 2680 Opioid Crisis Response Act
FY 2019 LHHS Appropriations related to HRSA Title VIII nursing workforce programs; Rehabilitation Research; Traumatic Brain Injury.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · third_quarter · Q3
H.R. 1409 Cancer Drug Parity Act; S. 2554/HR. 6143 Patient Right to Know Drug Prices Act; Opioid Monitoring; Drug pricing Monitoring; S. 2680 Opioid Crisis Response Act; H.R.6 Support for Patients and Communities Act.
FY 18 Labor Health & Human Services and Education (HHS) appropriations related to cancer programs.
ARE YOU DENSE ADVOCACY, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · third_quarter · Q3
S. 2006, The Breast Density and Mammography Reporting Act.
Filing targets: Food & Drug Administration (FDA), SENATE
OVARIAN CANCER RESEARCH FUND ALLIANCE via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · third_quarter · Q3
FY 2019 Labor, Health & Human Services and Education (HHS) appropriations related to ovarian cancer programs.
INTERNATIONAL MYELOMA FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · third_quarter · Q3
H.R. 1409 The Cancer Drug Parity Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SPINA BIFIDA ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · third_quarter · Q3
FY 2019 Health and Human Services (HHS) appropriations supporting the NSBP at the CDC.
Filing targets: HOUSE OF REPRESENTATIVES
HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · second_quarter · Q2
FY 18 Labor Health & Human Services and Education (HHS) appropriations related to cancer programs.
H.R. 1409 Cancer Drug Parity Act; H.R. 5247, Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018; S. 2554/HR. 6143 Patient Right to Know Drug Prices Act; Opioid Monitoring; Drug pricing Monitoring, HR. 592/ S. 109 Pharmacy and Medically Underserved Areas Enhancement Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SPINA BIFIDA ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · second_quarter · Q2
FY 2019 Health and Human Services (HHS) appropriations supporting the NSBP at the CDC.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERNATIONAL MYELOMA FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · second_quarter · Q2
H.R. 1409 The Cancer Drug Parity Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE REHABILITATION INNOVATION CENTERS COALITION via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · second_quarter · Q2
Impatient Rehabilitation Issues; HR 4582/ S 2204 Preserving Rehabilitation Innovation Centers Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PATIENT ACCESS NETWORK FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · second_quarter · Q2
Patient assistance programs.
ARE YOU DENSE ADVOCACY, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · second_quarter · Q2
S. 2006/ H.R. 4122, The Breast Density and Mammography Reporting Act.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF REHABILITATION NURSES via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · second_quarter · Q2
FY 2019 LHHS Appropriations related to HRSA Title VIII nursing workforce programs.
OVARIAN CANCER RESEARCH FUND ALLIANCE via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · second_quarter · Q2
FY 2019 Labor, Health & Human Services and Education (HHS) appropriations related to ovarian cancer programs.
HELENA AGRI-ENTERPRISES LLC via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · second_quarter · Q2
Agriculture and farm bill issues; HR 1029, Pesticide Registration Improvement Extension Act; S. 3032 Strengthening the Tenth Amendment Through Entrusting States Act; HR. 4881 Precision Agriculture Connectivity Act of 2018.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · second_quarter · Q2
Mental health issues; Opioid Issues; Draft opioid legislation; Including Families in Mental Health Recovery Act; S. 2524 Substance Use Disorder Workforce Loan Repayment Act of 2018; S. 2680 Opioid Crisis Response Act; HR. 6 Support for Patients and Communities Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INTERNATIONAL MYELOMA FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · first_quarter · 1A
H.R. 1409 The Cancer Drug Parity Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SPINA BIFIDA ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · first_quarter · Q1
FY 2018 Health and Human Services (HHS) appropriations supporting the National Spina Bifida Program at the Centers for Disease Control (CDC); H.R. 1625, the Consolidated Appropriations Act, FY 2019 Health and Human Services (HHS) appropriations supporting the NSBP at the CDC.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · first_quarter · Q1
HR 592/ S. 109, Pharmacy and Medically Underserved Areas Enhancement Act.
Mental health issues; Opioid Issues; House Ways and Means Committee letter on opioid crisis; finance committee letter on opioid crisis; HR 4778/ S. 2301, the Behavior Health Coverage Transparency Act; HR 3991, The Expanded Access to Opioid Abuse Treatment Act; HR 2345, the National Suicide Hotline Improvement Act; HR 5311/ S. 2456, the CARA 2.0 Act; HR 3692/ S 2317 Addiction Treatment Access Improvement Act.
FY 2018 Appropriations (Consolidated Appropriation Act) related to health professions (HRSA Title VII) and opioids; FY 19 appropriation (LHHS) related to health professions (HRSA Title VII) and opioids.
PREVENT BLINDNESS via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · first_quarter · Q1
FY 2018 HHS appropriations related to vision health/ HR 1625 the Consolidated Appropriations Act; FY 2019 Labor Health and Human Services and Education (HHS) appropriations related to vision; eye health
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PATIENT ACCESS NETWORK FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · first_quarter · Q1
Patient assistance programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · first_quarter · Q1
H.R. 1409 Cancer Drug Parity Act; H.R. 5247, Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018; letter to Finance Committee on opioid crisis; Letter to Ways & Means Committee on opioid crisis.
FY 18 Labor Health & Human Services and Education (HHS) appropriations related to cancer programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OVARIAN CANCER RESEARCH FUND ALLIANCE via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · first_quarter · Q1
FY 2018 Omnibus Appropriations Bill (HR 1625, the Consolidated Appropriations Act); FY 2019 Labor, Health & Human Services and Education (HHS) appropriations related to ovarian cancer programs.
Filing targets: HOUSE OF REPRESENTATIVES
INTERNATIONAL MYELOMA FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · first_quarter · Q1
H.R. 1409 The Cancer Drug Parity Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARE YOU DENSE ADVOCACY, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · first_quarter · Q1
S. 2006/ H.R. 4122, The Breast Density and Mammography Reporting Act.
PREVENT BLINDNESS via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · fourth_quarter · Q4
FY 2018 HHS appropriations related to vision health.
Filing targets: Health & Human Services, Dept of (HHS)
HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · fourth_quarter · Q4
H.R. 1409 Cancer Drug Parity Act
S. 109/ H.R. 592- The Pharmacy and Medically Undeserved Areas Enhancement Act.
FY 18 Labor Health & Human Services and Education (HHS) appropriations related to cancer programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · fourth_quarter · Q4
Mental health issues; Opioid Issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OVARIAN CANCER RESEARCH FUND ALLIANCE via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · fourth_quarter · Q4
HR 1409 The Cancer Drug Parity Act.
SPINA BIFIDA ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · fourth_quarter · Q4
FY 2018 Health and Human Services (HHS) appropriations supporting the National Spina Bifida Program at the Centers for Disease Control (CDC).
INTERNATIONAL MYELOMA FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · fourth_quarter · Q4
H.R. 1409 The Cancer Drug Parity Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PATIENT ACCESS NETWORK FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · fourth_quarter · Q4
Patient assistance programs.
Filing targets: HOUSE OF REPRESENTATIVES
ARE YOU DENSE ADVOCACY, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · fourth_quarter · Q4
S. 2006/ H.R. 4122, The Breast Density and Mammography Reporting Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF REHABILITATION NURSES via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · fourth_quarter · Q4
FY 2018 LHHS Appropriations related to HRSA Title VIII nursing workforce programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HELENA AGRI-ENTERPRISES LLC via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · fourth_quarter · Q4
Agriculture and farm bill issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PATIENT ACCESS NETWORK FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · fourth_quarter · RR
Introduction of the Patient Access Network Foundation
OVARIAN CANCER RESEARCH FUND ALLIANCE via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · third_quarter · Q3
Johanna's Law Reauthorization; Ovarian Cancer Awareness.
2018 Labor, Health, and Human Services and Education appropriations related to ovarian cancer.
ASSOCIATION OF REHABILITATION NURSES via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · third_quarter · Q3
FY 2018 LHHS Appropriations related to HRSA Title VIII nursing workforce programs.
SPINA BIFIDA ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · third_quarter · Q3
FY 2018 Health and Human Services (HHS) appropriations supporting the National Spina Bifida Program at the Centers for Disease Control (CDC).
INTERNATIONAL MYELOMA FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · third_quarter · Q3
H.R. 1409 The Cancer Drug Parity Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARE YOU DENSE ADVOCACY, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · third_quarter · Q3
Introduction of Breast Density and Mammography Reporting bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · third_quarter · Q3
FY 18 Labor Health & Human Services and Education (HHS) appropriations related to cancer programs.
S. 109/ H.R. 592- The Pharmacy and Medically Undeserved Areas Enhancement Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · third_quarter · Q3
Mental health issues; Opioid Issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARE YOU DENSE ADVOCACY, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · second_quarter · Q2
Introduction of Breast Density and Mammography Reporting bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · second_quarter · Q2
H.R. 1409 Cancer Drug Parity Act
FY 17 and FY 18 Labor Health & Human Services and Education (HHS) appropriations related to cancer programs.
S. 109/ H.R. 592- The Pharmacy and Medically Undeserved Areas Enhancement Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PREVENT BLINDNESS via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · second_quarter · Q2
FY 2017 and FY 2018 HHS appropriations related to vision health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERNATIONAL MYELOMA FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · second_quarter · Q2
H.R. 1409 The Cancer Drug Parity Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SPINA BIFIDA ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · second_quarter · Q2
FY 2017 and 2018 Health and Human Services (HHS) appropriations supporting the National Spina Bifida Program at the Centers for Disease Control (CDC).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · second_quarter · Q2
Mental health issues; Opioid Issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF REHABILITATION NURSES via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · second_quarter · Q2
S. 870 Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017; Chronic care return; Value based purchasing.
FY 2018 LHHS Appropriations related to HRSA Title VIII nursing workforce programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OVARIAN CANCER RESEARCH FUND ALLIANCE via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · second_quarter · Q2
Johanna's Law Reauthorization.
FY 2017 and 2018 Labor, Health, and Human Services and Education appropriations related to ovarian cancer.
Filing targets: Centers For Disease Control & Prevention (CDC)
OVARIAN CANCER RESEARCH FUND ALLIANCE via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · first_quarter · Q1
FY 2017 and 2018 Labor, Health, and Human Services and Education appropriations related to ovarian cancer.
HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · first_quarter · Q1
Cancer drug parity issue.
FY 17 and FY 18 Labor Health & Human Services and Education (HHS) appropriations related to cancer programs.
S. 109/ H.R. 592- The Pharmacy and Medically Undeserved Areas Enhancement Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERNATIONAL MYELOMA FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · first_quarter · Q1
H.R. 1409 The Cancer Drug Parity Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PREVENT BLINDNESS via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · first_quarter · Q1
FY 2017 and FY 2018 HHS appropriations related to vision health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF REHABILITATION NURSES via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · first_quarter · Q1
HR 1155 Cardiac Rehabilitation; Promoting appropriate quality measures and outcomes across the post-acute continuum
Put a Registered Nurse in the Nursing Home Act; Chronic care reform; Preserve access to quality rehabilitation services.
Filing targets: HOUSE OF REPRESENTATIVES
COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · first_quarter · Q1
Mental health issues
ARE YOU DENSE ADVOCACY, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · first_quarter · Q1
Introduction of Breast Density and Mammography Reporting bill
Filing targets: SENATE
COLLEGE OF PSYCHIATRIC AND NEUROLOGIC PHARMACISTS via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · first_quarter · RR
Treatment and care of individuals with mental illness
ASSOCIATION OF REHABILITATION NURSES via FAEGRE DRINKER BIDDLE & REATH LLP
2016 · fourth_quarter · Q4
S. 3504, the Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2016
HR 952 - Put a Registered Nurse in the Nursing Home Act.
Filing targets: SENATE
PREVENT BLINDNESS via FAEGRE DRINKER BIDDLE & REATH LLP
2016 · fourth_quarter · Q4
FY 2017 and FY 2018 HHS appropriations related to vision health; Racial and ethnic approaches to community health program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARE YOU DENSE ADVOCACY, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2016 · fourth_quarter · Q4
S 370/H.R.716, the Breast Density and Mammography Reporting Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SPINA BIFIDA ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2016 · fourth_quarter · Q4
Activities to support Spina Bifida on the Hill through Congressional Caucus.
Filing targets: HOUSE OF REPRESENTATIVES
HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2016 · fourth_quarter · Q4
S. 1566/HR 2739 - Cancer Drug Coverage Parity Act; 21st Century Cures Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERNATIONAL MYELOMA FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2016 · fourth_quarter · Q4
S. 1566/HR 2739 - Cancer Drug Coverage Parity Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2016 · third_quarter · Q3
S. 1566/HR 2739 - Cancer Drug Coverage Parity Act; Cancer moonshot.
S. 314/ HR 592 the Pharmacy and Medically Underserved Areas Enhancement Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Vice President of the U.S.
OVARIAN CANCER RESEARCH FUND ALLIANCE via FAEGRE DRINKER BIDDLE & REATH LLP
2016 · third_quarter · Q3
H. Res. 811/ S. Res. 521, recognizing September as Ovarian Cancer Awareness Month; H. 2739/ S. 1566 the Cancer Drug Coverage Parity Act; Activities to support ovarian cancer awareness month related to congressional caucus; Johanna's law implementation.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
INTERNATIONAL MYELOMA FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2016 · third_quarter · Q3
S. 1566/HR 2739 - Cancer Drug Coverage Parity Act.
Filing targets: HOUSE OF REPRESENTATIVES
ASSOCIATION OF REHABILITATION NURSES via FAEGRE DRINKER BIDDLE & REATH LLP
2016 · third_quarter · Q3
HR 952 - Put a Registered Nurse in the Nursing Home Act; HR 2799/ S 1465- Furthering Access to Stroke Telemedicine Act; HR 3355/ S 488- legislation to allow cardiac and pulmonary rehabilitation programs to be supervised by nurse practitioners.
ARE YOU DENSE ADVOCACY, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2016 · third_quarter · Q3
S 370, the Breast Density and Mammography Reporting Act
Filing targets: SENATE
CURE SMA via FAEGRE DRINKER BIDDLE & REATH LLP
2016 · third_quarter · Q3
FY 2017 Labor HHS appropriations issues related to spinal muscular atrophy.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
PREVENT BLINDNESS via FAEGRE DRINKER BIDDLE & REATH LLP
2016 · third_quarter · Q3
FY 2017 HHS appropriations related to vision health
HR 1312/ S 898- the National Health Services Corps Improvement Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HELENA AGRI-ENTERPRISES LLC via FAEGRE DRINKER BIDDLE & REATH LLP
2016 · third_quarter · RR
Regulatory policy regarding farming
PREVENT BLINDNESS via FAEGRE DRINKER BIDDLE & REATH LLP
2016 · second_quarter · Q2
FY 2017 HHS appropriations related to vision health
S. 2777, Contact Lens Consumer Health Protections Act.
Medicare Part B Demo.
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
HEMATOLOGY/ONCOLOGY PHARMACY ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2016 · second_quarter · Q2
S. 1566/HR 2739 - Cancer Drug Coverage Parity Act; Cancer Moonshot Initiative.
Letter to Senate Finance Committee regarding chronic pain policy paper; S. 314/ HR 592 the Pharmacy and Medically Underserved Areas Enhancement Act; Medicare Part B Drug Payment Demo model.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Vice President of the U.S.
INTERNATIONAL MYELOMA FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2016 · second_quarter · Q2
S. 1566/HR 2739 - Cancer Drug Coverage Parity Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE